Akeso Inc.

Akeso Inc.

World Rank (Aug-2026)
2105
Market Cap (Aug-2026)
10.602 Billion USD
World Rank (Jan-05-2024)
3,098
Market Cap (Jan-05-2024)
4.668 Billion USD
World Rank (Jul-30-2023)
3,179
Market Cap (Jul-30-2023)
4.631 Billion USD
World Rank (Jan-07-2022)
4,903
Market Cap (Jan-07-2022)
2.949 Billion USD
Company Rank in Country in 2023
Rank in China in July-2023 is 501
Headquarters Country
China
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
443 Million USD
Annual Operating Income in USD
-123 Million USD
Annual Net Income in USD
-161 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
2,318 Million USD
Total Liabilities in USD
1,022 Million USD
Total Equity in USD
1,296 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biotechnology
Company Website
AKESO, INC.
Company Profile
Akeso, Inc. is a biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of new innovative antibody drugs that are affordable to patients worldwide. The headquarters is in China.
Stock Exchange
HKeX

Share